Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: borredo

You wrote about $ 1 B in total fees reflecting a shareprice of $ 2.50.

 

It is known that there are approximately 220 companies in discussions, and 30 companies in advanced negotiations. I would expect all of these to settle with(in) one year of the J's settling, with the 30 settling within 6 - 8 weeks of any J settlement.

For the sake of argument, give PTSC $1 billion from the above license fees, $2.50 per share, now what?

 

My question relates to the P/E if the above occurs. Are you suggesting that it should be in the 40's or above, in the knowledge that there will be fewer potential licensees going forward?

 

 

Be well

 

 

Share
New Message
Please login to post a reply